Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infi
Go back to Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infi| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 131.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $131.78 | 52 Week High | $5.84 | |||
| Open | $131.78 | 52 Week Low | $5.49 | |||
| Day High | $131.78 | P/E | N/A | |||
| Day Low | $131.78 | EPS | $0.00 | |||
| Volume | 148 | |||||
| Nuvel Holdings, Inc. (NASDAQ: NUVL) | Delayed: 123.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.43 | 52 Week High | $0.40 | |||
| Open | $123.43 | 52 Week Low | $0.14 | |||
| Day High | $123.43 | P/E | N/A | |||
| Day Low | $123.43 | EPS | $-0.56 | |||
| Volume | 596 | |||||
